Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
04/2007
04/04/2007CN1939911A Chiral oxazoline and its production
04/03/2007US7199143 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus
04/03/2007CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents
04/03/2007CA2281918C Oxazolidines as 5-ht2a-antagonists
03/2007
03/29/2007WO2007034254A2 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007WO2007034035A1 Sulphonamide derivatives
03/29/2007WO2007015809A3 Hiv reverse transcriptase inhibitors
03/29/2007WO2006127909A3 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate
03/29/2007WO2006122250A3 Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
03/29/2007US20070073093 Light emitting device and compounds for use therein
03/29/2007US20070072964 Oxazole spiro derivative; easier, less expensive manufacture; incorporated in a coating composition for topcoat, clearcoat layers; against the effects of oxygen and light
03/29/2007US20070072871 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
03/29/2007DE102005045518A1 New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
03/29/2007CA2623326A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007CA2622086A1 Sulphonamide derivatives
03/28/2007EP1767530A1 Benzoxazoles
03/28/2007EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds
03/28/2007EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/28/2007EP1765793A1 Cetp inhibitors
03/28/2007CN1938287A Phenoxyacetic acid derivative and medicine containing the same
03/28/2007CN1938279A Modulators of atp-binding cassette transporters
03/28/2007CN1938266A Sulfonamide compounds for the treatment of neurodegenerative disorders
03/28/2007CN1935897A 树脂组合物 Resin composition
03/28/2007CN1935787A Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
03/27/2007US7196198 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis
03/27/2007US7196107 Thia-and oxazoles and their use as ppars activators
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/26/2007CA2576900A1 Hindered amine light stabilizer, methods of making, and compositions
03/22/2007WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/22/2007WO2007032028A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors
03/22/2007US20070066823 CCR9 inhibitors and methods of use thereof
03/22/2007US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/22/2007US20070066577 Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
03/22/2007CA2622518A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors
03/22/2007CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide
03/21/2007EP1763502A1 Novel hexafluoroisopropanol derivatives
03/21/2007EP1373170A4 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
03/21/2007CN1934907A 有机电致发光元件 Organic electroluminescent element
03/21/2007CN1931847A Prepn process of chiral 4-substituent-2-oxazolidone
03/20/2007US7193103 Reacting an admixture of N-(3,3-dimethylbutyl)-L-aspartic acid and a ketone or an acetal of a ketone in a first solvent for a time and at a temperature sufficient to produce an oxazolidinone derivative, reacting with L-phenylalanine or L-phenylalanine methyl ester in a second solvent
03/20/2007US7192965 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives
03/20/2007CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production
03/15/2007WO2007030386A2 An improved process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
03/15/2007WO2007030385A2 A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
03/15/2007WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2006106437A8 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
03/15/2007US20070060587 Indane derivates as muscarinic receptor agonists
03/15/2007US20070060584 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
03/15/2007US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction
03/15/2007CA2621971A1 An improved process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
03/15/2007CA2621961A1 A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
03/15/2007CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/14/2007EP1761485A1 Amidino compounds as cysteine protease inhibitors
03/14/2007CN1930153A Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
03/14/2007CN1930121A Substituted heteroaryl- and phenylsulfamoyl compounds
03/14/2007CN1927848A Substituted acid compounds, preparation method and medicament use thereof
03/14/2007CN1927843A Compound of 2-substituted alkylacrylate and application thereof
03/14/2007CN1304393C Substituted pyrazolone derivatives and their preparing process and pharmaceutical conpositions
03/14/2007CN1304392C Method for synthesizing 3-(5'-substitution-2-benzoxazole group)-7-diethyl amino group H-1-benzopyrans-2-ketone
03/14/2007CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals
03/13/2007US7189857 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives
03/13/2007US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology
03/13/2007US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis
03/13/2007US7189712 For therapy of hyperproliferative diseases
03/13/2007CA2274756C Methods and pharmaceutical compositions for inhibiting tumour cell growth
03/08/2007WO2007026753A1 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue
03/08/2007WO2007025709A2 Organic compounds
03/08/2007WO2006127893A3 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
03/08/2007US20070055067 Process for preparing oxazolidine protected aminodiol compounds useful as intermediates to Florfenicol
03/08/2007US20070055066 Process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
03/08/2007US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
03/08/2007US20070054883 Use controlling growth of quorum-sensing bacteria, controlling biofilm formation, including biofilm growth; cyclic borate, phosphate or sulfate compounds
03/08/2007CA2620222A1 Organic compounds
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1758664A2 Process employing controlled crystallization in forming crystals of a pharmaceutical
03/07/2007EP1444038B1 Process for performing an enantioselective catalytic Hetero-Diels-Alder reaction
03/07/2007CN1926118A Dimeric small molecule potentiators of apoptosis
03/07/2007CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors
03/07/2007CN1925854A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/07/2007CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
03/07/2007CN1303043C Process for producing biaryl compound
03/06/2007US7186844 Alkyl- or phenyl-substituted 2-oxazolidinones; reacting a dihalo compound with a primary amine and carbon dioxide; nontoxic; industrial scale
03/06/2007US7186738 antibiotics such as (5R)-3-[3-Fluoro-4-(3-methylisoxazol-5-yl)phenyl]-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one, having effective activity against both grampositive and gramnegative pathogens
03/06/2007US7186735 Vasodilation; cardiovascular disorders; anticoagulants
03/06/2007CA2168319C 4-mercaptobenzoylguanidine derivatives
03/06/2007CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/01/2007WO2007023141A1 N-oxides as prodrugs of piperazine & piperidine derivatives
03/01/2007US20070049759 Methods for Preparing N-Arylated Oxazolidinones Via A Copper Catalyzed Cross Coupling
03/01/2007US20070049628 Benzoxazole inhibitors of 15-lipoxygenase
03/01/2007US20070049594 Novel compounds and compositions as cathepsin inhibitors
03/01/2007CA2621158A1 N-oxides as prodrugs of piperazine & piperidine derivatives
02/2007
02/28/2007EP1757596A1 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama
02/28/2007EP1757292A1 Method of treating ocd and tic disorders
02/28/2007EP1756071A1 Benzoxazolone derivatives, processes for preparing them and their uses
02/28/2007EP1755585A1 Transthyretin stabilization
02/28/2007EP1265606B9 Cell adhesion inhibitors
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 210